Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Exploring motor imagery abilities in individuals with aphantasia

Official title: Probing and Modulating Motor Imagery Capacities in Aphantasia

Run by Hôpital le Vinatier · NCT06140940 · Data updated 2026-11-12

This study is testing if a brain stimulation treatment can help people with aphantasia improve their ability to imagine movements compared to those who can visualize normally.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorHôpital le Vinatier
Academic / other
Locations1 site (Bron)
StatusRecruiting
StartedMarch 28, 2024
Main results expectedJanuary 1, 2027
Study endsJanuary 1, 2028
Registry record updatedJuly 24, 2025
Trial IDNCT06140940 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with congenital aphantasia who have a lifelong inability to generate mental imagery.

Probably not a fit

Patients with a history of neurological or mental illness, or those with musculoskeletal disorders affecting the upper limb, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the motor imagery abilities of individuals with aphantasia by comparing them to those with typical mental imagery. It aims to characterize the neurophysiological and physiological aspects of motor imagery in both groups. Participants with aphantasia will undergo non-invasive brain stimulation (tDCS) while performing a mental imagery task, with the goal of determining if this intervention can enhance their mental imagery capabilities. The study employs a randomized, double-blind, sham-controlled, crossover design to ensure robust results.

Why it matters

Potential benefit: If successful, this study could lead to improved mental imagery abilities in individuals with aphantasia, enhancing their cognitive and functional outcomes.

How similar studies have gone: While the approach of using tDCS for enhancing mental imagery is innovative, similar studies have shown promise in other cognitive domains, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* For the aphantasia group only: congenital aphantasia defined as a life-long inability to generate mental imagery (confirmed by a total score of 32 or less on the VVIQ, which is the gold standard questionnaire for aphantasia)
* For the no-aphantasia group only: typical mental imagery capacities (confirmed by a total score of more than 32 on the VVIQ)
* Covered by public health insurance
* Understanding the French language
* Signed written informed consent after being informed about the study

Exclusion Criteria:

* Presence or history of a somatic, neurologic, or mental illness
* Actual pain or musculoskeletal disorders at the upper limb
* Having a regular musical activity (more than once a week) because of high manual dexterity
* Contraindication for noninvasive brain stimulation including the presence of ferromagnetic or magnetic sensitive metal objects implanted in the head or in close proximity (e.g., brain stent, clip, cochlear implants, or stimulator)
* Pregnancy (controlled by urine pregnancy test in females without reported contraception)
* Active seizure disorder or history of seizures
* Participants under curatorship/guardianship

Where it's running

  • Centre Hospitalier le Vinatier
    Bron, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.